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Eugenio Picano, MD, PhDa Pisa, Florence, Italy; and Madrid, SpainBackground Occupational doses from fluoroscopy-guided interventional procedures are the highest ones
registered among medical staff using x-rays. The aim of the present study was to evaluate the order of magnitude of cancer
risk caused by professional radiation exposure in modern invasive cardiology practice.
Methods From the dosimetric Tuscany Health Physics data bank of 2006, we selected dosimetric data of the
26 (7 women, 19 men; age 46 ± 9 years) workers of the cardiovascular catheterization laboratory with effective dose
N2 mSv. Effective dose (E) was expressed in milliSievert, calculated from personal dose equivalent registered by the
thermoluminescent dosimeter, at waist or chest, under the apron, according to the recommendations of National
Council of Radiation Protection. Lifetime attributable risk of cancer was estimated using the approach of Biological
Effects of Ionizing Radiation 2006 report VII.
Results Cardiac catheterization laboratory staff represented 67% of the 6 workers with yearly exposure N6 mSv.
Of the 26 workers with 2006 exposure N2 mSv, 15 of them had complete records of at least 10 (up to 25) consecutive years.
For these 15 subjects having a more complete lifetime dosimetric history, the median individual effective dose was
46 mSv (interquartile range = 24-64). The median risk of (fatal and nonfatal) cancer (Biological Effects of Ionizing
Radiation 2006) was 1 in 192 (interquartile range = 1 in 137-1 in 370).
Conclusions Cumulative professional radiological exposure is associated with a non-negligible Lifetime attributable
risk of cancer for the most exposed contemporary cardiac catheterization laboratory staff. (Am Heart J 2009;157:118-24.)Use of radiation for medical examinations and tests is
the largest artificial source of radiation exposure.1
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hgraphy and coronary angiography correspond to a
radiation exposure of about 300 chest x-rays; a
coronary stent to 1,000; a peripheral artery intervention
to 1,500-2,500; and a cardiac radiofrequency ablation to
900 up to several thousands.4-8 In most cases, it is the
cardiologist who performs these procedures, often
without any specific training in radiology and radiation
protection.9 Although there is a general appreciation
that radiation by itself is certainly not a good thing for
the patient or the operator, radiation safety is rarely
much of an overt concern to interventionalist.10
Interventional cardiology is developing at a rate that is
ahead of both the supporting research and regulatory
framework, and growth in the field has been accom-
panied by concern for the safety of the staff directly
involved in such high radiation procedures (European
DIMOND Action II 1999 and III 2001).11 Occupational
doses in interventional procedures guided by fluoro-
scopy are the highest doses registered among medical
staff using x-rays.12-14 The aims of this present study are
Table I. Cardiac catheterization laboratory population and
dosimetric data
Age (y) 46 ± 9
Gender (male/female) 19/7
Role
Interventional cardiologist 18 (69%
Cardiac electrophysiologists 4 (15%)
Catheterization laboratory nurse 3 (11%)
Catheterization laboratory technician 1 (4%)
Last year (2006) dosimetry (mSv/year) 4.8 ± 4.6
Years of employment in catheterization laboratory 15 ± 10
Figure 1
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Volume 157, Number 1)Bar histograms showing proportions of yearly dose exposure in al
medical staff censored in Tuscany Health Physics Department (Pisa
and Florence) for the year 2006. The histograms refer to the overal
population of hospital workers broken down by specialties and
increasing levels of exposure (from no threshold, far left histogram, to
exposure N6 mSv/year, far right histogram). The proportion from
cardiac catheterization laboratory workers rises with progressively
higher exposure threshold.to assess the current levels of professional exposure in
the modern invasive cardiology practice and to estimate
the corresponding levels of long-term lifetime attribu-
table cancer risks.
Methods
Selection of subjects
We initially considered all health professionals included in
2006 in the Tuscany Region dosimetric data bank, collected in
the Health Physics Departments of Pisa and Florence and
composed of N50 hospitals, including 11 high volume cardiac
catheterization laboratories. From this initial set of 5,164
workers, we selected cardiac catheterization laboratory staff
(interventional cardiologists, cardiac electrophysiologists, inter-
ventional radiologists, nurses, technicians) and analyzed the
yearly exposure. For catheterization laboratory workers with
yearly 2006 exposure N2 mSv, we calculated the entire
professional exposure whenever possible. All subjects enrolled
gave their written informed consent and allowed the recon-
struction of their lifetime cumulative professional exposure from
official records of the Health Physics Department (Table I). The
study is a part of a larger study on health effects of low-dose
radiation exposure and was approved by local Ethical Commit-
tee. The study was also endorsed by the Italian Association of
Hospital Cardiologists (ANMCO) and endorsed by the Tuscany
Health Physics Association.
Individual dose reconstruction
In accordance with the recommendations of the Interna-
tional Commission on Radiological Protection (ICRP)15 and
Directive 96/29/EURATOM,16 radiation dose to workers was
expressed as effective dose. Staff dosimetry was obtained by a
thermo luminescent dosimeter, with monthly measurement.
The dosimeter was located under the lead apron, at the waist,
or over the chest. Dosimeter results were converted to
effective dose as suggested by the ICRP.17 Generally, personal
dosimeter services provide monthly estimates of Hp,10 the
dose equivalent in soft tissue at 10-mm depth, which is usually
compared with the limit of the effective dose, set by ICRP at
100 mSv in 5 years18 and usually used as 20 mSv/year.
Calculation of risk
To calculate cumulative risk of stochastic effects, we used
the age and gender-dependent risk factors from the multi-
plicative model recommended in the most recent report froml
lthe Biological Effects of Ionising Radiation Committee VII
(BEIR VII) for (fatal and nonfatal) cancer.19 Currently, in the
risk model for low-level exposures, a linear relationship
between dose and risk is used. According to these estimates, it
is predicted that for 100 mSv effective doses in adults,
approximately 1 individual in 200 would develop fatal cancer,
and 1 in 100 would develop fatal or nonfatal cancer.19 The
attributable lifetime risk of radiation-induced cancer for all
members of the population may be estimated by multiplying
the effective dose in milliSievert by the fatal cancer coefficient
of 5.5 × 10−5 for the whole population and by 4.1 × 10−5 for
adult workers. Because we dealt with a population of adult
workers, we used the latter coefficient.19 According to BEIR
VII estimates for lifetime attributable risk (LAR) of cancer
incidence and mortality, receiving 2 mSv per year from ages
18 to 65 (48 years working time) represents (number of cases
per 100,000 exposed persons) 612 for men and 859 for
women (incidence) and 340 for men and 478 for women
(mortality). Thus, for a population of 50% males and 50%
females, these values would be 736 (incidence) and 409
(mortality). Thus, according to BEIR VII, the total cancer
incidence receiving 2 mSv/y from 18 to 65 should be 1 in 136
and the total mortality 1 in 245 workers.
Statistical analysis
Data were expressed as median, 25 to 75 percentiles, and
range for nonnormally distributed values. Linear regression and
Pearson correlationwere used to assess the relationship between
cumulative radiological effective dose and age. The Kruskal-
Wallis test was performed to determine any significant differ-
ences among the groups.
Figure 2
Bar histograms showing the yearly (2006) individual dose exposure
(in mSv, x-axis) and the number of cardiac catheterization laboratory
workers (upper panel) and other professionals (lower panel) with
radiation exposure (y-axis).
Figure 3
Exposure in the year 2006 (on y-axis) for the 26 workers with
exposure N2 mSv/year.
Figure 4
Box-and-whiskers plot showing the median dose exposure (in mSv, x
axis) and the calculated LAR of cancer (y-axis) for catheterization
laboratory workers at 3 different time points of their dosimetric
natural history in a busy professional life. The box represents the
interquartile range that contains the 50% of values. The whiskers are
lines that extend from the box to the highest and lowest values
excluding outliers. A line across the box indicates the median. All o
the 26 Tuscany cardiac catheterization laboratory workers with
exposure N2 mSv in year 2006 are shown at 1-year exposure (green
box); a subset of 15 workers is shown at 10 years (yellow box); the
same 15 workers with cumulative (11-25 years) professiona
exposure reconstruction are shown in the red box.
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(version 11.0, SPSS Inc, Chicago, IL). A P value b.05 was
considered significant.
Results
For the total population of 5,164 workers, we assessed
the yearly exposure as distributed throughout the
medical specialties. Cardiac catheterization laboratory
workers represented 67% of workers with yearly
exposure N6 mSv and 31% of those with exposure N1 mSv
(Figure 1). When the full population of cardiac catheter-
ization laboratory personnel is considered, the exposure
levels are relatively low and comparable with those of
other specialties with radiation exposure (Figure 2). The
2006 dose exposure of the 26 cardiac catheterization
laboratory workers with exposure N2 mSv was divided
according to subspecialty and professional role
(Figure 3). Interventional cardiologists (median 3.3, range
2.0-19.6 mSv/y) and cardiac electrophysiologists (median
4.3, range 3.5-6.1 mSv/y) have high and comparable,
professional exposure, and nurses and technicians may
show similar values (median 2.6, range 2.0-14.9 mSv/y,
P = NS vs the other groups). Cumulative doses (and
corresponding risks) are shown in Figure 4 at 3 discrete
time points in the natural history of a high-volume cardiac
catheterization laboratory worker: at 1 year (for 26 car--
,
f
ldiac catheterization laboratory workers with 2006 dose
exposure N2 mSv), at 10 years (for a subset of 15 workers
who reached this milestone: P b .0001 vs 1 year
exposure), and lifetime (for the same 15 workers with
exposures longer than 10 years, ranging from 11 to
25 years; P = .001 vs 10 year exposure). For these
15 subjects with a more complete lifetime dosimetric
history, the median individual effective dose was 46 mSv
(interquartile range 24-64). There was a significant
correlation between cumulative radiological effective
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catheterization laboratory activity (r = .47, P = .02). The
median value of risk of fatal cancer was 1 in 384. The
median risk of (fatal and nonfatal) cancer (BEIR 2006) was
1 in 192 (interquartile range = 1 in 137-1 in 370).Discussion
In contemporary medical practice, catheterization
laboratory workers comprised most of those with high
levels of exposure. For the most experienced (and most
exposed) staff working in the cardiac catheterization
laboratory, with a range of exposures in between 2 and
5 mSv per year, a typical cumulative 15-year radiological
exposure around the equivalent of 50 mSv is associated
with a nonnegligible LAR of cancer in the order of
magnitude of 1 cancer in 200 exposed subjects. This
applies, however, only at the individuals with the highest
exposure, the tip of the iceberg. When the full spectrum
of catheterization laboratory workers are considered (not
only those with the very highest exposure), the exposure
levels are fully comparable with those of other specialties
with radiation exposure.
Comparison with previous studies
Very variable estimated effective doses to patients
can be found for coronary intervention5,6 and cardiac
electrophysiological20-23 procedures, with higher values
reported for coronary stenting and ablation procedures
(around 15 to 25 mSv, ranging from 2 to 60 mSv) and
lower values for diagnostic procedures such as coronary
angiography or electrophysiologic study (around 3 to
5 mSv, ranging from 1 to 20 mSv). Regarding medical
personnel, the rates of risk of death for cancer for
both kind of procedures (electrophysiologic procedures
and interventional cardiology) depend on the radio-
protection measures of the professionals and the radia-
tion dose to the patients, and a wide range of values can
be found in the literature. A few microSieverts per
electrophysiology20 and similar values for catheterization
procedures,24-27 with a risk per procedure of developing
a fatal cancer of the operator in the 1 in 500,000 to 1 in
1,000,000.27 In reality, with a 100 μSv exposure per
procedure,20,27-30 the risk of cancer (fatal and nonfatal)
would be after BEIR in the range of 1 in 100,000 per
procedure. However, it should be highlighted that the
lack of a good radioprotection policy could increase
occupational doses (and risk of cancer) in a factor of 10.31
The professional risk in perspective
The risks from continuous occupational exposure
peaks in the seventh, eighth, and ninth decade of
life.32,33 The risk compares favorably with many other
occupations. Working in agriculture is associated to
320, in construction to 227, in mines to 167 days of lost
life expectancy.34 An occupation with b1 fatality per10,000 workers per year is considered a safe occupa-
tion by the National Council of Radiological Protec-
tion.35 The risk of the average interventional
cardiologist/radiologist is below this risk throughout the
radiologist's career, up to a career of 40 years,36 if the
basic radiation protection rules are followed. Only after
working N40 years would the annual radiation risk
exceed the risk level now considered safe by the
National Council on Radiation Protection. However, this
overall reassuring picture should be integrated with
some prudent concern if we consider, as we probably
should, lifetime (not only annual) risk, and fatal and
nonfatal (not only fatal) cancer risk. Safety discussion
should also consider the spectacularly growing popula-
tion of highly exposed staff, not only the “average”
exposure of catheterization laboratory people, which
may have a highly heterogeneous activity within the
same catheterization laboratory. For highly exposed
personnel with 5-mSv yearly exposure, lifetime extra
risk for (fatal or nonfatal) cancer after 20 years of
professional life is in the range of 1 in 100. Although
this exposure remains well below the dose limit of
occupational exposure, consisting of an effective dose
of 20 mSv in a year averaged over a period of 5 years,15
it can neither be considered negligible or harmless.37
Uncertainties in risk estimates
At present, both the radiology community38-40 and
advisory bodies1,15,19,35 are well aware of the carcino-
genic effect of low-dose ionizing radiation used in
medical diagnostic testing—as well as the degree of
approximations and uncertainties in current risk esti-
mation, that is, risk can be 2 to 3 times higher or lower
than current estimates.19 Nevertheless, these estimates
represent the best available scientific evidence and
should be considered benchmark values for both the
scientist and the clinician.38-40 The threshold of
conclusive epidemiological evidence linking radiation
and cancer is at 50 mSv—a threshold that only some of
the most active cardiac catheterization laboratory
workers trespass with the working exposure alone, and
a significant number of professionals are still not using
their personal dosimeters on a regular basis37,41 and
more cases of high doses between professionals could
not be included in the official data basis. Recent
epidemiologic and cytogenetic data corroborate the
available risk estimates, reducing the room of uncer-
tainty.32 Health professionals exposed to low dose
radiation, as for instance interventional cardiologists or
radiologists with an average exposure of 4 mSv/year,
show a 2-fold increase in circulating lymphocytes of
chromosome aberrations and/or micronuclei, which
represent surrogate biomarkers of cancer risk and
intermediate end points of carcinogenesis.42-44 There-
fore, the available risk estimates should not be
considered either perfect or precise, but certainly
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of both patients and physicians.
Study limitations
A primary limitation is that the wearing of radiation
badges is subject to the user's capacity of remembering to
put the badge on, and we did not have an estimation of
the compliance for wearing of radiation badges. It is
known that one third of catheterization laboratory staff is
negligent in wearing the dosimeters,31,41,45-47 which may
represent a source of significant underestimation of
calculated risk. Moreover, we recruited our occupational
dose data from Tuscany (Pisa and Florence) Health
Physics Department. There are recognized, wide varia-
tions in national and even regional practice, depending
on radiation protection measures taken, medical specia-
lization, typology and number of procedures, legal and
regulatory framework. Staff doses to catheterization
laboratory staff can vary by a factor of 10 within a given
hospital41 and by a factor of 12 between hospitals.48 An
additional limitation is that we have evaluated doses
under the apron (chest or waist). It is a common practice
in radioprotection to directly compare Hp10 with the
limit of the effective dose.49 Wearing an additional
dosimeter at collar level above lead apron would provide
an indication of the head (eye) dose and a better
approximation (combined with under apron dosimetry)
of the whole body dose.18 However, ICRP report 85
(2001) states that “a single dosimeter worn under the lead
apron will yield a reasonable estimate of effective dose for
most instances”15—although on the basis of recent
evidences, the possibility of an underestimation of dose,
with a variable multiplying factor ranging from 1.5 to 7,50
cannot be excluded. Finally, our risk estimates were
derived from population estimates and did not include
diagnostic radiation exposure applied on the worker as a
patient.51,52 Many environmental and genetic factors may
modulate the individual vulnerability to oncogenic effects
of radiation, and the next step is to translate epidemio-
logical estimates to tailored risk assessment on the basis
of gene polymorphisms and personalized biomarker
evaluation, for instance with micronuclei and/or chro-
mosome aberrations in peripheral lymphocytes, which
are an intermediate end point and a long-term predictor
of cancer.32Conclusions
The number of interventional radiological (and especially
cardiological) procedures has been increasing during the
last years. The number of involved professionals (cardiol-
ogists, nurses, and technicians) is also substantially
increasing. The highest doses to staff (and to patients) are
usually recorded in these laboratories. With current staff
exposure levels, professional risk cannot be considered
negligible, for the most exposed personnel workers in thecardiac catheterization laboratories, whereas the exposure
level of the full spectrum of catheterization laboratory
participants is acceptably low and comparable to those of
other specialties with radiation exposure. However, a wide
margin for optimization aimed to reduce patient and staff
doses exists. The quest for optimization is one of the
aspects, and probably not the least important, to assess the
quality of the catheterization laboratory. Most recent
professional guidelines on interventional cardiology of the
American Heart Association/American College of Cardiol-
ogy clearly state that “the responsibility of all physicians is
to reduce the radiation injury hazard to their patients, to
their professional staff and to themselves.”53 The assess-
ment of radiation exposure is also “a required part of the
safety outcome in every trial that includes fluoroscopy-
based interventions or radiation-based imaging,” as recently
recommended by the European Heart Rhythm Association
in the design of future trials on atrial fibrillation.54 The
challenge ahead is to implement guidelines and recom-
mendations into everyday clinical practice. This should
remodulate the current dose exposure of our most
experienced interventional cardiologists on a more
sustainable trajectory.
We are grateful to Manuella Walker, BSc, for the
English revisions of the manuscript and to Sabrina
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